Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guaifenesin is an expectorant used to relieve chest congestion and facilitate the removal of mucus from the respiratory tract. It is commonly found in over-the-counter cough and cold medications. Guaifenesin works primarily by increasing the volume and reducing the viscosity of bronchial secretions through stimulation of the gastric mucosa or possibly direct action on respiratory epithelium. This process enhances mucociliary clearance and makes coughs more productive[1][2][4][5]. There is also evidence suggesting minor central antitussive effects and possible NMDA receptor antagonism[4][5]. Guaifenesin does not treat underlying causes of symptoms but helps manage them by thinning mucus for easier expulsion. It is indicated for temporary symptomatic relief from chest congestion due to colds or flu.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on guaifenesin.